105 related articles for article (PubMed ID: 16271499)
1. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation.
Clemens MJ
Int J Biochem Cell Biol; 2006 Feb; 38(2):164-9. PubMed ID: 16271499
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.
McKenna SA; Kim I; Liu CW; Puglisi JD
J Mol Biol; 2006 May; 358(5):1270-85. PubMed ID: 16580685
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells.
Nanbo A; Yoshiyama H; Takada K
J Virol; 2005 Oct; 79(19):12280-5. PubMed ID: 16160154
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal protein L22 inhibits regulation of cellular activities by the Epstein-Barr virus small RNA EBER-1.
Elia A; Vyas J; Laing KG; Clemens MJ
Eur J Biochem; 2004 May; 271(10):1895-905. PubMed ID: 15128299
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress.
Wong HL; Wang X; Chang RC; Jin DY; Feng H; Wang Q; Lo KW; Huang DP; Yuen PW; Takada K; Wong YC; Tsao SW
Mol Carcinog; 2005 Oct; 44(2):92-101. PubMed ID: 16086371
[TBL] [Abstract][Full Text] [Related]
6. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
Yajima M; Kanda T; Takada K
J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
[TBL] [Abstract][Full Text] [Related]
7. The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis.
Nanbo A; Takada K
Rev Med Virol; 2002; 12(5):321-6. PubMed ID: 12211044
[TBL] [Abstract][Full Text] [Related]
8. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR.
Ruf IK; Lackey KA; Warudkar S; Sample JT
J Virol; 2005 Dec; 79(23):14562-9. PubMed ID: 16282456
[TBL] [Abstract][Full Text] [Related]
9. Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line.
Ji Jung E; Mie Lee Y; Lan Lee B; Soo Chang M; Ho Kim W
Anticancer Drugs; 2007 Jan; 18(1):79-85. PubMed ID: 17159505
[TBL] [Abstract][Full Text] [Related]
10. The role of EBERs in oncogenesis.
Takada K; Nanbo A
Semin Cancer Biol; 2001 Dec; 11(6):461-7. PubMed ID: 11669608
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA.
Sharp TV; Schwemmle M; Jeffrey I; Laing K; Mellor H; Proud CG; Hilse K; Clemens MJ
Nucleic Acids Res; 1993 Sep; 21(19):4483-90. PubMed ID: 7901835
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation.
Laing KG; Elia A; Jeffrey I; Matys V; Tilleray VJ; Souberbielle B; Clemens MJ
Virology; 2002 Jun; 297(2):253-69. PubMed ID: 12083824
[TBL] [Abstract][Full Text] [Related]
13. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
14. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
Ng SB; Khoury JD
Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
[TBL] [Abstract][Full Text] [Related]
16. Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.
Wensing B; Stühler A; Jenkins P; Hollyoake M; Karstegl CE; Farrell PJ
J Virol; 2001 Jul; 75(13):6235-41. PubMed ID: 11390629
[TBL] [Abstract][Full Text] [Related]
17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
18. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus-induced expression of a novel human vault RNA.
Nandy C; Mrázek J; Stoiber H; Grässer FA; Hüttenhofer A; Polacek N
J Mol Biol; 2009 May; 388(4):776-84. PubMed ID: 19298825
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome.
Elia A; Laing KG; Schofield A; Tilleray VJ; Clemens MJ
Nucleic Acids Res; 1996 Nov; 24(22):4471-8. PubMed ID: 8948637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
